In Mozambique, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories in Maputo, Nampula, Beira and Quelimane. However, test volumes are growing and many parts of the country do not have close access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are now new POC EID technologies becoming available that will enable diagnosis of HIV in infants within minutes or a couple of hours on site in the clinic, operated by non technical staff and without laboratory infrastructure. This protocol describes a plan to conduct an evaluation of a Point-Of-Care (POC) Early Infant Diagnosis (EID) testing technologies that are being considered for use in Mozambique, and to pilot those technologies in order to provide more effective diagnostics and clinical care to patients. During this implementation pilot, sites are randomized to use either conventional or POC EID testing only before the inclusion of the patients in the study. No consent will be asked to the parents or guardians. A written permission will be asked to the Direção Provincial de Saúde of both provinces to implement the POC device as routine in those intervention sites. All the information that will be analyzed will be collected from the routine care and it will be analyzed as a group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
179
Centro de Saude Moamba
Moamba, Maputo Province, Mozambique
Centro de Saude de Manga Loforte
Beira, Sofala, Mozambique
Centro de Saude de Ponta Gea
Beira, Sofala, Mozambique
Centro de Saude Munhava
Beira, Sofala, Mozambique
Centro de Saude NHACONJO
Beira, Sofala, Mozambique
Centro de Saude de Machava II
Maputo, Mozambique
Centro de Saude Matola Gare
Maputo, Mozambique
Centro de Saúde de Khongolote
Maputo, Mozambique
The proportion of HIV-positive infants initiating antiretroviral therapy within 60 days of sample collection
Time frame: up to 6 months
the proportion of HIV-positive infants who initiated antiretroviral therapy that were retained in care at 90 days of follow-up.
Patients were considered retained in care at 90 days if they had visited the health facility within the previous 30 days.
Time frame: 3 months after treatment initiation
The median age at time of results received by patient
Time frame: Up to 6 months
The median number of days between specimen collection and results received by patient
Time frame: Up to 6 months
The median age at time of antiretroviral treatment initiation
Time frame: Up to 6 months
The median number of days between specimen collection and initiation of antiretroviral treatment.
Time frame: Up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.